Ardeparin Subcutaneous and Morphine Extended-Release Capsules
Determining the interaction of Ardeparin Subcutaneous and Morphine Extended-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ardeparin
Brand name: Baciguent, Probiotic Formula, Proferrin-ES
Synonyms: Ardeparin (Subcutaneous)
Generic Name: morphine
Brand name: Arymo ER, Kadian, MorphaBond ER, MS Contin, Avinza, Duramorph PF, Infumorph, Mitigo, RMS, Roxanol
Synonyms: Morphine, Morphine (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ardeparin Subcutaneous-Morphine Immediate-Release Tablets and Capsules
- Ardeparin Subcutaneous-Morphine injection
- Ardeparin Subcutaneous-Morphine Injection PF
- Ardeparin Subcutaneous-Morphine Long-Acting Tablets
- Ardeparin Subcutaneous-Morphine Oral Concentrate (20 mg/mL)
- Ardeparin Subcutaneous-Morphine Oral Solution
- Morphine Extended-Release Capsules-Aredia
- Morphine Extended-Release Capsules-Arestin
- Morphine Extended-Release Capsules-Arestin eent
- Morphine Extended-Release Capsules-Arestin mucous membrane powder
- Morphine Extended-Release Capsules-Arformoterol
- Morphine Extended-Release Capsules-Arformoterol inhalation